VC  Lancet Capital

     Office Locations:

100 Technology Dr., Suite 200
Pittsburgh, PA 15219
Phone: 412-402-9914
Fax: 412-452 - 9480



  • Early
  • Seed



  • Life Sciences & Healthcare
  • Medical Device



    Lancet Capital, the first SBIC affiliated with an academic medical center, was founded in 1998 by William Golden and George Sing to create value for investors and founders/management of early stage biomedical portfolio companies. Lancet invests in exceptional researchers, clinicians and entrepreneurs to commercialize innovative technologies in the biomedical field. Lancet Capital has been actively supporting promising adult stem cell research for over ten years, including seeding, founding and providing executive management.

    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Growth Stage
    (also called Mid-stage)
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B

    Investment Team:

    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription.
    George L. Sing Managing Director
    William J. Golden Co-Founder & Managing Director


    Portfolio companies include:


    Recent News:

      There is no recent news for Lancet Capital.